Four Great Growth Funds

Investors who want to skip the hassle of buying individual growth stocks have plenty of fine funds to choose from.

Investors who want to skip the hassle of buying individual growth stocks have plenty of fine funds to choose from. Will Danoff, who manages Fidelity Contrafund (symbol FCNTX), a member of the Kiplinger 25, seeks growing industry leaders and doesn't agonize over the price he pays for a stellar name. The fund's 3.0% annualized return over the past ten years through July 31 beats 95% of large-company growth funds. But the fund's immensity -- it has $50 billion in assets -- means it is heavily biased toward large- and mega-capitalization stocks.

For a more targeted approach to the mid-cap slice of the market -- where companies tend to be leaner and better able to sustain high growth rates -- T. Rowe Price Mid-Cap Growth (RPMGX), also a member of the Kiplinger 25, is a fine option. Manager Brian Berghuis likes companies that, aided by such things as patents or potent brand names, build strong defenses against their competitors, and he tends to pay more attention to balance sheets and share price than other growth-fund managers do. The fund's 5.2% annualized return over the past ten years beats 82% of mid-cap growth funds.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%
https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-200-80.png

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

To continue reading this article
please register for free

This is different from signing in to your print subscription


Why am I seeing this? Find out more here

Elizabeth Leary
Contributing Editor, Kiplinger's Personal Finance
Elizabeth Leary (née Ody) first joined Kiplinger in 2006 as a reporter, and has held various positions on staff and as a contributor in the years since. Her writing has also appeared in Barron's, BloombergBusinessweek, The Washington Post and other outlets.